loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r0_cep_2018_037___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Kewpie Corporation

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    EXCIPIENTS

    EXCIPIENTS BY INGREDIENTS

    EXCIPIENTS BY APPLICATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 KEWPIE CORPORATION Tokyo JP (1)

    filter

    01 Sodium hyaluronate, Intrinsic viscosity 1.28 m3/kg; 1.63 m3/kg, by fermentation, for parenteral administration including intra-articular administration and for intra-ocular use (1)

    filter

    01 Japan (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    KEWPIE CORPORATION Tokyo JP

    Contact Supplier
    • FDA
    Virtual BoothKewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.
    Contact Supplier Contact Supplier
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Sodium hyaluronate, Intrinsic viscosity 1.28 m3/kg; 1.6...

    PDF Supplier PDF
    URL Supplier Web Content
    R0-CEP 2018-037 - Rev 01
    Valid
    Chemical and TSE
    2021-03-24
    1472
    Kewpie Company Banner

    CPhI China

    Exhibiting

    envelop Contact Supplier

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2018-037 - Rev 01 of Kewpie Corporation Tokyo Jp

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2018-037 - Rev 01 of Kewpie Corporation Tokyo Jp 1

    20

    Kewpie Corporation Tokyo Jp, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA.

    They are recognized for Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    One of their significant offerings is Sodium hyaluronate, Intrinsic viscosity 1.28 m3/kg; 1.63 m3/kg, by fermentation, for parenteral administration including intra-articular administration and for intra-ocular use, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2018-037 - Rev 01

    This Chemical and TSE Type CEP, issued on March 24, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 1472 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY